SANTA CLARA, Calif., Nov. 07, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat severely ...
As medtech companies eye entry into the IVL space, Shockwave Medical is consolidating its position through innovation and ...
MARIETTA, GA - June 09, 2026 - - Shockwave Centers of America provides information on radial shockwave therapy as a ...
FREMONT, Calif., Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today announced clearance from the U.S. Food and Drug Administration (FDA) of the Lithoplasty ® ...
FREMONT, Calif. & WASHINGTON--(BUSINESS WIRE)--Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today reported positive safety, performance and intravascular imaging ...
SANTA CLARA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...
Shockwave Medical, Inc. SWAV, along with Genesis MedTech Group, received approval from China’s National Medical Products Administration for Intravascular Lithotripsy (“IVL”). The clearance paves the ...
Please provide your email address to receive an email when new articles are posted on . ATLANTA — In patients with calcified peripheral artery disease undergoing drug-coated balloon treatment, ...
Evidence on the safety of extracorporeal shockwave therapy for calcific tendinopathy in the shoulder shows no major safety concerns in the short term. Evidence on efficacy is inadequate. Therefore, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results